Trastuzumab Targeted Neratinib Loaded Poly-Amidoamine Dendrimer Nanocapsules for Breast Cancer Therapy

BACKGROUND: Human epidermal growth factor receptor2 (Her2) positive breast cancer represents 25% of breast cancer cases. Targeted therapy with Her2 monoclonal antibody, trastuzumab (TZ), represents the first-line treatment for this type of breast cancer. In addition, neratinib, an irreversible inhib...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Nanomedicine
Hoofdauteurs: Aleanizy, Fadilah Sfouq, Alqahtani, Fulwah Yahya, Seto, Sara, Al Khalil, Nora, Aleshaiwi, Lama, Alghamdi, Manar, Alquadeib, Bushra, Alkahtani, Hamad, Aldarwesh, Amal, Alqahtani, Qamraa Hamad, Abdelhady, Hosam Gharib, Alsarra, Ibrahim
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398757/
https://ncbi.nlm.nih.gov/pubmed/32801698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S256898
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items